비뇨기과 영역에서의 인간면역결핍바이러스 감염

키워드

참고문헌 (111)

1. "2008 Report on the global AIDS epidemic"[URL]
2. Galvin SR, "The role of sexually transmitted diseases in HIV transmission", Nat Rev Microbiol, 2, pp.33~42 (2004)
3. Abrams P, "Evidence - based medicine overview of the main steps for developing and grading guideline recommendations", Prog Urol, 17, pp.681~684 (2007)
4. "U.S. Department of Health and Human Services Public Health Service Agency for Health Care Policy and Research", 115~127 (1992)
5. Royce RA, "Sexual transmission of HIV", N Engl J Med, 336, pp.1072~1078 (1997)
6. Chin J, "Heterosexual HIV transmission dynamics: implications for prevention and control", Int J STD AIDS, 18, pp.509~513 (2007)
7. Dyer JR, "Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture", J Virol Methods, 60, pp.161~170 (1996)
8. Vernazza PL, "Quantification of HIV in semen: correlation with antiviral treatment and immune status", AIDS, 11, pp.987~993 (1997)
9. Uvin SC, "Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women", Obstet Gynecol, 90, pp.739~743 (1997)
10. Coombs RW, "Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood", J Infect Dis, 177, pp.320~330 (1998)
11. Dyer JR, "Shedding of HIV-1 in semen during primary infection", AIDS, 11, pp.543~545 (1997)
12. Chakraborty H, "Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model", AIDS, 15, pp.621~627 (2001)
13. Hart CE, "Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract", J Infect Dis, 179, pp.871~882 (1999)
14. Chakraborty H, "Estimating correlation by using a general linear mixed model: evaluation of the relationship between the concentration of HIV-1 RNA in bloodand semen", Stat Med, 22, pp.1457~1464 (2003)
15. Gupta P, "High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors", J Virol, 71, pp.6271~6275 (1997)
16. Padian NS, "Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study", Am J Epidemiol, 146, pp.350~357 (1997)
17. Nicolosi A, "The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission", Epidemiology, 5, pp.570~575 (1994)
18. de Vincenzi I, "A longitudinal study of human immunodeficiency virus transmission by heterosexual partners, in the European Study Group on Heterosexual Transmission of HIV", N Engl J Med, 331, pp.341~346 (1994)
19. Gray RH, "Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda", Lancet, 357, pp.1149~1153 (2001)
20. Mastro TD, "HIV type 1 transmission probabilities: estimates from epidemiological studies", AIDS Res Hum Retroviruses, 14(3), pp.223~227 (1998)
21. Fleming DT, "From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection", Sex Transm Infect, 75, pp.3~17 (1999)
22. Rottingen JA, "A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?", Sex Transm Dis, 28, pp.579~597 (2001)
23. Coombs RW, "Recent observations on HIV type-1 infection in the genital tract of men and women", AIDS, 17, pp.455~480 (2003)
24. Buonaguro L, "Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications", J Virol, 81, pp.10209~10219 (2007)
25. Gao F, "The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A", E) recombinant of African origin, 1996, pp.70, 7013~7029
26. van Harmelen J, "An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa", AIDS, 11, pp.81~87 (1997)
27. Avila MM, "Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups", J Acquir Immune Defic Syndr, 29, pp.422~426 (2002)
28. Buonaguro L, "Evolution of the HIV-1 V3 region in the Italian epidemic", New Microbiol, 30, pp.1~11 (2007)
29. Buonaguro L, "Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example", Retrovirology, 4, pp.34~ (2007)
30. Tagliamonte M, "Genetic and phylogenetic characterization of structural genes from non-B HIV-1 subtypes in Italy", AIDS Res Hum Retroviruses, 22, pp.1045~1051 (2006)
31. Grosskurth H, "Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial", Lancet, 346, pp.530~536 (1995)
32. Wawer MJ, "Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial, in the Rakai Project Study Group", Lancet, 353, pp.525~535 (1999)
33. Gray RH, "Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda", Am J Obstet Gynecol, 185, pp.1209~1217 (2001)
34. Kamali A, "Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial", Lancet, 361, pp.645~652 (2003)
35. Hay P, "HIV transmission and sexually transmitted infections", Clin Med, 8, pp.323~326 (2008)
36. Nagot N, "Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus", N Engl J Med, 356, pp.790~799 (2007)
37. Rebbapragada A, "Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract", AIDS, 21, pp.589~598 (2007)
38. Kaul R, "The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission", J Reprod Immunol, 77, pp.32~40 (2008)
39. Sheth PM, "Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation", J Infect Dis, 193, pp.45~48 (2006)
40. Casper C, "Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial", J Infect Dis, 198, pp.23~30 (2008)
41. Auvert B, "Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial", PLoS Med, 2, pp.298~ (2005)
42. Bailey RC, "Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial", Lancet, 369, pp.643~656 (2007)
43. Gray RH, "Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial", Lancet, 369, pp.657~666 (2007)
44. Powers KA, "Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis", Lancet Infect Dis, 8, pp.553~563 (2008)
45. Katz IT, "Circumcision - a surgical strategy for HIV prevention in Africa", N Engl J Med, 359, pp.2412~2415 (2008)
46. "Incorporating HIV Prevention into the Medical Care of Persons Living with HIV. CDC Morbidity & Mortality Weekly Report (MMWR)" (2003)[URL]
47. Marrazzo J, "Syphilis and other sexually transmitted diseases in HIV infection", Top HIV Med, 15, pp.11~16 (2007)
48. Centers for Disease Control and Prevention (CDC), "Twenty five years of HIV", AIDS-United States 1981-2006, 2006, pp.55, 585~589
49. Marks G, "Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs", J Acquir Immune Defic Syndr, 39, pp.446~453 (2005)
50. Centers for Disease Control and Prevention, "Revised recommendations for HIV testingof adults, adolescents, and pregnant women in the health care setting", MMWR Recom R, ~ (2006)
51. Branson BM, "State of the art for diagnosis of HIV infection", Clin Infect Dis, 45(4), pp.221~225 (2007)
52. Wesolowski LG, "Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing", AIDS, 20, pp.1661~1666 (2006)
53. Yeni P, "Update on HAART in HIV", J Hepatol, 44(1), pp.100~103 (2006)
54. Hammer SM, "A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team", N Engl J Med, 335, pp.1081~1090 (1996)
55. Deeks SG, "HIV-1 protease inhibitors. A review for clinicians", JAMA, 277, pp.145~153 (1997)
56. Hammer SM, "Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society- USA panel", JAMA, 300, pp.555~570 (2008)
57. Hoepelman AI, "Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count)", AIDS, 6, pp.179~184 (1992)
58. Lee LK, "The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome", BJU Int, 88, pp.500~510 (2001)
59. Hyun G, "AIDS and the urologist", Urol Clin North Am, 30, pp.101~109 (2003)
60. Miles BJ, "The urological manifestations of the acquired immunodeficiency syndrome", J Urol, 142, pp.771~773 (1989)
61. Heyns CF, "The urological management of the patient with acquired immunodeficiencysyndrome", BJU Int, 95, pp.709~716 (2005)
62. Kwan DJ, "Acquired immunodeficiency syndrome. A venereal disease", Urol Clin North Am, 19, pp.13~24 (1992)
63. Steele BW, "Recognizing the urologic manifestations of HIV and AIDS", Contemp Urol, 9, pp.39~53 (1997)
64. Kaplan MS, "Urologic manifestations of AIDS", Urology, 30, pp.441~443 (1987)
65. O’Regan S, "AIDS and the urinary tract", J Acquir Immune Defic Syndr, 3, pp.244~251 (1990)
66. Leport C, "Bacterial prostatitis in patients infected with the human immunodeficiency virus", J Urol, 141, pp.334~336 (1989)
67. De Paepe ME, "Testicular atrophy in AIDS: a study of 57 autopsy cases", Hum Pathol, 20, pp.210~214 (1989)
68. Blattner WA, "Human retroviruses: their role in cancer", Proc Assoc Am Physicians, 111, pp.563~572 (1999)
69. Bellan C, "Pathologic aspects of AIDS malignancies", Oncogene, 22, pp.6639~6645 (2003)
70. Dal Maso L, "Epidemiology of AIDS-related tumours in developed and developing countries", Eur J Cancer, 37, pp.1188~1201 (2001)
71. Silverberg MJ, "AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era", Curr Opin Oncol, 19, pp.446~451 (2007)
72. Bower M, "AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy", Curr Opin Infect Dis, 19, pp.14~19 (2006)
73. Grulich AE, "Decreasing rates of Kaposi’s sarcoma and non-Hodgkin’s lymphoma in the era of potent combination anti-retroviral therapy", AIDS, 15, pp.629~633 (2001)
74. Pollok RC, "Kaposi’s sarcoma in the kidney", Int J STD AIDS, 6, pp.289~290 (1995)
75. Weil DA, "Kaposi’s sarcoma of the testicle", AIDS Read, 9, pp.455~461 (1999)
76. Lowe FC, "Kaposi’s sarcoma of the penis in patients with acquired immunodeficiency syndrome", J Urol, 142, pp.1475~1477 (1989)
77. Baynham SA, "Increased prevalence of renal cell carcinoma in patients with HIV infection", AIDS Patient Care STDS, 11, pp.161~165 (1997)
78. Wilson WT, "Testicular tumors in men with human immunodeficiency virus", J Urol, 147, pp.1038~1040 (1992)
79. Armenakas NA, "AIDS presenting as primary testicular lymphoma", Urology, 40, pp.162~164 (1992)
80. Vianna LE, "Serum prostate- specific antigen levels in older men with or at risk of HIV infection", HIV Med, 7, pp.471~476 (2006)
81. zur Hausen H, "Human papillomaviruses", Annu Rev Microbiol, 48, pp.427~447 (1994)
82. Wang CY, "Skin cancers associated with acquired immunodeficiency syndrome", Mayo Clin Proc, 70, pp.766~772 (1995)
83. Schwartz EJ, "Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease", J Am Soc Nephrol, 16, pp.2412~2420 (2005)
84. Shahinian V, "Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients", Am J Kidney Dis, 35, pp.884~888 (2000)
85. Winston JA, "Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection", N Engl J Med, 344, pp.1979~1984 (2001)
86. Szczech LA, "Protease inhibitors are associated with a slowed progressionof HIV-related renal diseases", Clin Nephrol, 57, pp.336~341 (2002)
87. Atta MG, "Antiretroviral therapy in the treatment of HIV-associated nephropathy", Nephrol Dial Transplant, 21, pp.2809~2813 (2006)
88. Atta MG, "HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management", Expert Rev Anti Infect Ther, 6, pp.365~371 (2008)
89. Kane CJ, "Voiding dysfunction in human immunodeficiency virus infections", J Urol, 155, pp.523~526 (1996)
90. Hermieu JF, "Micturition disturbances and human immunodeficiency virus infection", J Urol, 156, pp.157~159 (1996)
91. Bruce RG, "Urolithiasis associated with the protease inhibitor indinavir", Urology, 50, pp.513~518 (1997)
92. Gentle DL, "Protease inhibitor-induced urolithiasis", Urology, 50, pp.508~511 (1997)
93. Salahuddin S, "Is indinavir crystalluria an indicator for indinavir stone formation?", AIDS, 15, pp.1079~1080 (2001)
94. Daudon M, "Urinary stones in HIV-1positive patients treated with indinavir", Lancet, 349, pp.1294~1295 (1997)
95. Kalaitzis C, "Urological management of indinavir-associated acute renal failure in HIV-positive patients", Int Urol Nephrol, 39, pp.743~746 (2007)
96. Schrooten W, "Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment", AIDS, 15, pp.1019~1023 (2001)
97. Sollima S, "Protease inhibitors and erectile dysfunction", AIDS, 15, pp.2331~2333 (2001)
98. Lamba H, "Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men", Int J STD AIDS, 15, pp.234~237 (2004)
99. Lallemand F, "Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors", J Acquir Immune Defic Syndr, 30, pp.187~190 (2002)
100. Merry C, "Interaction of sildenafil and indinavir when co-administered to HIV-positive patients", AIDS, 13, pp.101~107 (1999)
101. Sangani P, "Populationbased interventions for reducing sexually transmitted infections, including HIV infection", Cochrane Database Syst Rev, pp.001220~ (2004)
102. Atashili J, "Bacterial vaginosis and HIV acquisition: a metaanalysis of published studies", AIDS, 22, pp.1493~1501 (2008)
103. Cameron DW, "Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men", Lancet, 2, pp.403~407 (1989)
104. Plummer FA, "Cofactors in male-female sexual transmission of human immunodeficiency virus type 1", J Infect Dis, 163, pp.233~239 (1991)
105. Laga M, "Non-ulcerative sexually transmitted diseases as risk factors for HIV-1transmission in women: results from a cohort study", AIDS, 7, pp.95~102 (1993)
106. Taha TE, "Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV", AIDS, 12, pp.1699~1706 (1998)
107. Martin HL, "Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition", J Infect Dis, 180, pp.1863~1868 (1999)
108. Myer L, "Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study", J Infect Dis, 192, pp.1372~1380 (2005)
109. Cohen MS, "Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group", Lancet, 349, pp.1868~1873 (1997)
110. Ghys PD, "The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d’Ivoire", AIDS, 11, pp.85~93 (1997)
111. Stamm WE, "The association between genital ulcer disease and acquisition of HIV infection in homosexual men", JAMA, 260, pp.1429~1433 (1988)

관련 논문AI추천